SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

12 Aug 2025 Evaluate
The sales for the June 2025 quarter moved down to Rs. 384.49 millions as compared to Rs. 414.82 millions during the year-ago period.Net profit declined -27.51% to Rs. 16.36 millions from Rs. 22.57 millions.The Operating Profit of the company witnessed a decrease to 45.04 millions from 54.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 384.49 414.82 -7.31 384.49 414.82 -7.31 1514.63 1723.86 -12.14
Other Income 4.70 5.75 -18.26 4.70 5.75 -18.26 62.25 23.03 170.30
PBIDT 45.04 54.35 -17.13 45.04 54.35 -17.13 227.83 282.74 -19.42
Interest 5.62 6.78 -17.11 5.62 6.78 -17.11 30.45 43.77 -30.43
PBDT 39.42 47.57 -17.13 39.42 47.57 -17.13 197.38 238.97 -17.40
Depreciation 17.73 17.42 1.78 17.73 17.42 1.78 69.53 70.08 -0.78
PBT 21.69 30.15 -28.06 21.69 30.15 -28.06 127.85 168.89 -24.30
TAX 5.33 7.58 -29.68 5.33 7.58 -29.68 33.24 35.90 -7.41
Deferred Tax -0.37 -0.78 -52.56 -0.37 -0.78 -52.56 -3.15 -6.27 -49.76
PAT 16.36 22.57 -27.51 16.36 22.57 -27.51 94.61 132.99 -28.86
Equity 135.63 127.15 6.67 135.63 127.15 6.67 127.15 127.15 0.00
PBIDTM(%) 11.71 13.10 -10.59 11.71 13.10 -10.59 15.04 16.40 -8.29

Medicamen Biotech Share Price

242.55 0.10 (0.04%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×